GT Biopharma (GTBP) Stock Chart & Stock Price History $2.37 +0.08 (+3.49%) Closing price 03:48 PM EasternExtended Trading$2.36 -0.01 (-0.42%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GT Biopharma Stock Price Performance 5 Day Performance+1.08%1 Month Performance-8.79%3 Month Performance-0.64%6 Month Performance+17.34%Year-To-Date Performance-23.44%1 Year Performance-37.90% Receive GTBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address GTBP Stock Chart for Tuesday, April, 15, 2025 GTBP Chart by TradingViewRemove Ads GT Biopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/14/2025$2.23$2.29+2.69%$2.36$2.293,424 shs$5.81 million04/11/2025$2.31$2.23-3.46%$2.32$2.1610,741 shs$5.66 million04/10/2025$2.28$2.31+1.32%$2.39$2.159,989 shs$5.86 million04/09/2025$2.32$2.28-1.72%$2.40$2.1539,676 shs$5.78 million04/09/2025$2.32$2.28-1.72%$2.40$2.1539,676 shs$5.78 million04/08/2025$2.26$2.32+2.65%$2.49$2.2331,685 shs$5.88 million04/08/2025$2.26$2.32+2.65%$2.49$2.2331,685 shs$5.88 million04/07/2025$2.35$2.26-3.83%$2.47$2.1629,373 shs$5.73 million04/04/2025$2.33$2.35+0.86%$2.39$2.2017,138 shs$5.96 million04/03/2025$2.36$2.33-1.27%$2.45$2.1112,723 shs$5.91 million Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/02/2025$2.37$2.36-0.42%$2.46$2.3613,687 shs$5.99 million04/01/2025$2.15$2.37+10.23%$2.37$2.1016,750 shs$6.01 million03/31/2025$2.40$2.15-10.42%$2.45$2.1219,773 shs$5.45 million03/28/2025$2.30$2.40+4.35%$2.43$2.3515,611 shs$6.09 million03/27/2025$2.42$2.30-4.96%$2.50$2.2914,688 shs$5.83 million03/26/2025$2.36$2.42+2.54%$2.50$2.4013,200 shs$6.14 million03/25/2025$2.33$2.36+1.29%$2.40$2.3018,481 shs$5.99 million03/24/2025$2.50$2.33-6.80%$2.45$2.3214,472 shs$5.91 million03/21/2025$2.26$2.50+10.62%$2.50$2.2549,056 shs$6.34 million03/20/2025$2.40$2.26-5.83%$2.47$2.2625,084 shs$5.73 million03/19/2025$2.46$2.40-2.44%$2.54$2.3517,343 shs$6.24 million03/18/2025$2.40$2.46+2.50%$2.49$2.3338,279 shs$6.24 million03/17/2025$2.56$2.40-6.25%$2.55$2.4091,750 shs$6.09 million03/14/2025$2.48$2.56+3.23%$2.56$2.3220,465 shs$6.49 million Related Companies DURECT Stock Price Chart KALA BIO Stock Price Chart CalciMedica Stock Price Chart Grace Therapeutics Stock Price Chart Tenax Therapeutics Stock Price Chart LianBio Stock Price Chart Longeveron Stock Price Chart Finch Therapeutics Group Stock Price Chart JATT Acquisition Stock Price Chart Ovid Therapeutics Stock Price Chart Receive GTBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GTBP) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GTBP Stock Free GTBP Stock Alerts